Thereafter, the binding of TIM-3 with its ligands further caused the engagement of pro-apoptosis programs, which eventually led to the dysfunction of NK cells as well as the weakening anti-tumor immunity and poor prognosis of AML. The gene discussed is HAVCR2; the disease is acute myeloid leukemia.